SEC Tracker
Get the app

Rallybio RLYB

Rallybio to merge with Avenzo

Securities offering

Form
424B3
Filed
Importance
Routine
  1. Merger effective upon filing with Delaware Secretary of State
  2. Avenzo shareholders get 0.5020 shares of Rallybio
  3. Concurrent financing of $215M to close with merger
  4. Rallybio to change name to Avenzo Therapeutics

Written from the 424B3 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Rallybio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
  2. Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
  3. Scienture Holdings SCNX public float $10M, Jun 30, 2025
  4. Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
  5. Palisade Bio PALI public float $11M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.